We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Top Sells

Rank Stock Value
1
SIAL
SIGMA - ALDRICH CORP
SIAL
+$48.6M
2
JPM icon
JPMorgan Chase
JPM
+$47.9M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$46.2M
4
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
+$31.6M
5
KIM icon
Kimco Realty
KIM
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LPNT
426
DELISTED
LifePoint Health, Inc.
LPNT
$1.69M 0.04%
22,997
+18,104
+370% +$1.29M
GWW icon
427
W.W. Grainger
GWW
$66B
$1.68M 0.04%
+8,266
New +$1.7M
ACN icon
428
CALL
Accenture
ACN
$101B
$1.67M 0.04%
16,000
– –
ACN icon
429
PUT
Accenture
ACN
$101B
$1.67M 0.04%
16,000
– –
HELE icon
430
Helen of Troy
HELE
$672M
$1.67M 0.04%
17,733
+6,836
+63% +$684K
PMC
431
DELISTED
PharMerica Corporation
PMC
$1.67M 0.04%
+47,625
New +$1.49M
BSX icon
432
Boston Scientific
BSX
$68.5B
$1.66M 0.04%
+89,982
New +$1.61M
NVDA icon
433
CALL
NVIDIA
NVDA
$4.77T
$1.66M 0.04%
2,012,000
-772,000
-28% -$582K
BF.B icon
434
Brown-Forman Class B
BF.B
$13.3B
$1.65M 0.04%
52,041
-142,715
-73% -$4.76M
ADP icon
435
Automatic Data Processing
ADP
$106B
$1.65M 0.04%
+19,486
New +$1.68M
BMY icon
436
PUT
Bristol-Myers Squibb
BMY
$130B
$1.65M 0.04%
24,000
+16,000
+200% +$1.06M
USO icon
437
CALL
United States Oil Fund
USO
$2B
$1.65M 0.04%
+18,750
New +$2M
BNY
438
CALL
Bank of New York Mellon
BNY
$106B
$1.65M 0.04%
40,000
+16,000
+67% +$672K
BNY
439
PUT
Bank of New York Mellon
BNY
$106B
$1.65M 0.04%
40,000
+16,000
+67% +$672K
A icon
440
Agilent Technologies
A
$39.7B
$1.64M 0.04%
39,144
+23,875
+156% +$923K
ASH icon
441
Ashland
ASH
$3.11B
$1.64M 0.04%
32,553
-12,413
-28% -$654K
MSI icon
442
Motorola Solutions
MSI
$73.1B
$1.64M 0.04%
23,897
-29,697
-55% -$2.07M
LAMR icon
443
Lamar Advertising Co
LAMR
$16.5B
$1.63M 0.04%
27,198
+20,273
+293% +$1.17M
RMD icon
444
ResMed
RMD
$30.3B
$1.63M 0.04%
+30,357
New +$1.71M
EMN icon
445
CALL
Eastman Chemical
EMN
$7.79B
$1.62M 0.04%
24,000
+8,000
+50% +$560K
EMN icon
446
PUT
Eastman Chemical
EMN
$7.79B
$1.62M 0.04%
24,000
+8,000
+50% +$560K
CHRW icon
447
C.H. Robinson
CHRW
$20B
$1.61M 0.04%
25,970
+8,921
+52% +$601K
GRMN
448
CALL
Garmin
GRMN
$48.9B
$1.58M 0.04%
+42,500
New +$1.55M
PFE icon
449
Pfizer
PFE
$144B
$1.58M 0.04%
51,562
+25,336
+97% +$797K
MON
450
CALL
DELISTED
Monsanto Co
MON
$1.58M 0.04%
+16,000
New +$1.5M
16 17
18
19 20

Similar funds

PWMG
Prestige Wealth Management Group Flemington, New Jersey $509M AUM 15.69% 1-Year Est. Return
NIEF
Nalanda India Equity Fund Mauritius $510M AUM 23.61% 1-Year Est. Return
HIM
HughesLittle Investment Management Vancouver $511M AUM 24.72% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
OA
Oasis Advisors Forest City, Iowa $509M AUM
MC
Machina Capital Paris, France $508M AUM 9.91% 1-Year Est. Return
CTAF
Call To Action Foundation Salt Lake City, Utah $511M AUM 16.28% 1-Year Est. Return
MWAM
Manhattan West Asset Management Los Angeles, California $511M AUM 18.81% 1-Year Est. Return

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.